Clinical Trials Browser

NCT00052494 2015-07-23

Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 1 Completed

9 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01011075 2015-07-03

6137p

Phase 2 Completed

34 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02127372 2014-09-15

Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571

Phase 1/2 Terminated

43 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00323362 2014-05-22

Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer

Phase 2 Terminated

17 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00425646 2013-05-06

Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

50 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00248482 2013-04-29

Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2 Completed

6 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00222144 2012-08-07

Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer

Phase 2 Completed

23 enrolled

Thoracic

Lung Neoplasms

NCT01083589 2012-01-11

Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

22 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00193349 2010-06-28

Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer

Phase 2 Completed

60 enrolled

Thoracic

Lung Neoplasms